
OZURDEX
OZURDEX ® (dexamethasone intravitreal implant) is a prescription medicine that is an implant injected into the eye (vitreous) and used: To treat adults with diabetic macular edema To treat …
HOW IT WORKS - Ozurdex
OZURDEX ® (dexamethasone intravitreal implant) is a prescription medicine that is an implant injected into the eye (vitreous) and used: To treat adults with diabetic macular edema To treat …
What to Expect - Ozurdex
OZURDEX ® (dexamethasone intravitreal implant) is a prescription medicine that is an implant injected into the eye (vitreous) and used: To treat adults with diabetic macular edema To treat …
OZURDEX® for HCPs | Home
OZURDEX ® is a corticosteroid indicated for the treatment of macular edema following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO). Posterior Segment …
OZURDEX® (dexamethasone intravitreal implant) is a prescription medicine that is an implant injected into the eye (vitreous) and used to treat adults with swelling of the macula (macular …
OZURDEX® (dexamethasone intravitreal implant) is a prescription medicine that is an implant injected into the eye (vitreous) and used: • To treat adults with diabetic macular edema
About OZURDEX® | OZURDEX® for HCPs
OZURDEX ® is a sustained-release, biodegradable steroid implant containing dexamethasone, a corticosteroid 4; Dexamethasone has been shown to suppress inflammation, which can be a …
OZURDEX® Resources for Your Practice | OZURDEX® for HCPs
OZURDEX® (dexamethasone intravitreal implant) resources for practices and patients. Please see Important Safety Information and Prescribing Information.
OZURDEX® Mechanism of Action | OZURDEX® for HCPs
OZURDEX ® is a corticosteroid indicated for the treatment of macular edema following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO). Posterior Segment …
OZURDEX® Reimbursement Support | For HCPs
OZURDEX ® is indicated for the treatment of noninfectious uveitis affecting the posterior segment of the eye. Dosage and Administration FOR OPHTHALMIC INTRAVITREAL INJECTION.